Wegovy injection recalled due to temperature exposure during shipping
Cardinal Health is recalling Wegovy (semaglutide) 2.4 mg injection due to temperature abuse during shipping. Product was removed from refrigerated storage for an extended period due to a distribution center error.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving potential loss of product efficacy due to temperature excursion. The source text does not report any illnesses, injuries, or confirmed harm, and the hazard is storage-condition noncompliance rather than contamination or structural defect.
Plain-English summary
Cardinal Health Inc. is recalling Wegovy (semaglutide) 2.4 mg/0.75 mL injection in single-dose prefilled pens. The recall affects 48 cartons with lot number PZFDE06 (expiration 08/31/2025) distributed to North Carolina, South Carolina, and Virginia.
The product was potentially exposed to temperatures outside its labeled storage requirements due to a shipping error at a Cardinal Health distribution center. Specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
Consumers who have received affected product should contact their healthcare provider or pharmacist. The FDA classifies this recall as Class II.
The recalled product
- Product
- Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Injectable / Prescription
- Affected units
- 48
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot PZFDE06
- Exp 08/31/2025
Distribution
Related recalls
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- SevereEye drops recalled for non-sterility due to bacterial contamination
FDA (Drugs) · 2023-11-29
Same hazard · temperature abuse
See all →- SevereKayem Foods Recalls Ready-to-Eat Meat and Poultry Due to Temperature Abuse
USDA FSIS · 2026-10-17
- ModerateZoladex Goserelin Implant Recalled Due to Temperature Abuse
FDA (Drugs) · 2026-10-07
- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
Similar recalls
- ModerateCardinal Health Recalls Gemcitabine Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- HighWegovy prefilled pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- HighWegovy 0.5 mg pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- ModerateCardinal Health Recalls Cefazolin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- SevereCardinal Health Recalls Levofloxacin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateNovo Nordisk Recalls OZEMPIC Injection Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21